Pharmaceutical Packaging Geared to Serialization

IV Fluid Packaging

IV Fluid Packaging

Well-designed packaging aims at better promotion, targeted marketing, and enhanced sales. For the pharmaceutical industry, packaging plays another critical role in ensuring the efficient distribution and eventually, the safe consumption of drugs. More than 40 countries have introduced track-and-trace laws to help regulate product as it passes through the supply chain. While no two countries have passed the exact same requirements, by 2019, the majority of the world’s prescription medications will be protected by such legislation. Serializing products is the cornerstone of all these regulations.

Serialization is the term used to describe the unique identification of individual saleable units (instead of each batch). As each finished product is packaged, a unique code is assigned and physically marked on the packaging in the form of a code, which can be traced.

The demand for digital printing systems and the advantage they bring are clearly on the rise in the pharma industry. In order to serialize products, pharma companies or their contract partners are working on technology to support serialization in the fields of supply chain, marketing, design, and also printing. 

Printing on pharma packaging, such as blisters and IV bags, clearly require dedicated suitable inks. 

Dr Marc Graindourze

Dr Marc Graindourze

“The adoption of inkjet printing for blisters offers a natural fit with the requirement to print a unique code on each single blister pack. Inkjet system integrators heavily focus on inkjet units that either print off-line, near-line, or even in-line, aiming at a migration-safe print solution with dedicated sets of inks such as Agfa low-migration inks.” 

Agfa Graphics optimizes the overall performance of its digital inks so that they work perfectly together with printheads, substrates, application and the entire print system to fulfill the functional demands of each different application.

 “The functional requirements for direct print on primary medical/pharmaceutical plastic bags are not only very particular but also extremely demanding in case of IV-bags or blood bags. Implementing print before sterilization is the preferred process order, but is at the same time the most challenging with regards to ink performance and migration risks. Taking in account the complete printing solutions, Agfa’s low-migration UV-curable inks have proven to meet the expectations for this workflow, which offers unique opportunities for serialization in the pharma packaging industry.”

Blister tablet packaging

Blister tablet packaging


For further information contact:

Paul Adriaensen | Agfa Graphics
PR Manager Septestraat 27 | B-2640 Mortsel | Belgium
T  +32 3444 3940 | M  +32 494 56 02 19

E: paul.adriaensen@agfa.com